Guidelines for Clinical Trials of Frontal Fibrosing Alopecia: Consensus Recommendations from the International FFA Cooperative Group

    Elise A. Olsen, Matthew Harries, Antonella Tosti, Wilma F. Bergfeld, Ulrike Blume-Peytavi, Valerie D. Callender, Vasiliki Chasapi, Osvaldo Correia, George Cotsarelis, Rachita Dhurat, Ncoza C. Dlova, Isabella Doche, Nkechi Anne Enechukwu, Ramón Grimalt, Satoshi Itami, Maria Hordinsky, Kuzma Кhobzei, W. S. Lee, Subrata Malakar, Andrew G. Messenger, Amy J. McMichael, Paradi Mirmirani, Yuliya Ovcharenko, Sofia Papanikou, Giselle Martins Pinto, Bianca Maria Piraccini, Rodrigo Pirmez, P. Reygagne, Janet L. Roberts, Lidia Rudnicka, David Saceda‐Corralo, Jerry Shapiro, Tatiana Silyuk, Rodney Sinclair, Rui Oliveira Soares, A. Souissi, Annika Vogt, Ken Washenik, Abraham Zlotogorski, Douglas Canfield, Sergio Vañó‐Galván
    Image of study
    TLDR Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.
    The document outlines consensus recommendations from the International FFA Cooperative Group (IFFACG) for clinical trials on Frontal Fibrosing Alopecia (FFA), aiming to standardize diagnostic criteria, severity rating, staging, and assessment methods. The IFFACG, comprising hair loss experts, achieved over 90% agreement on these guidelines to ensure consistent and meaningful data collection on FFA worldwide. This will enhance clinical and basic research on well-defined patient populations and facilitate the evaluation of treatment efficacy and safety. The guidelines introduce a Global Staging Score and the ALODEXFFA Score for simplified assessment of hair density and extent, which are expected to improve data aggregation and support further research to fill existing knowledge gaps about FFA.
    Discuss this study in the Community →

    Research cited in this study

    37 / 37 results

    Related Community Posts Join

    6 / 377 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community 9 months on Fin - no progress , should I get on Dutasteride?

      in Chat  10 upvotes 2 weeks ago
      The user has been using finasteride, minoxidil, and nizoral for hair loss but hasn't seen regrowth, only maintenance. They are considering switching to dutasteride, which is believed to be more effective, but are concerned about potential side effects.

      community Testosterone and hair loss seeming irrelevance

      in Research/Science  81 upvotes 1 year ago
      The conversation is about the role of testosterone in hair loss and the effectiveness of different treatments. The conclusion is that DHT is the main culprit for hair loss, and finasteride has been proven to work long-term in maintaining and regrowing hair. Testosterone may have a minor effect, but it is not the primary cause of hair loss.

      community Diffuse thinning is so brutal.

      in Styling  72 upvotes 1 year ago
      A 25-year-old with AGA experienced hair thinning and dandruff, stabilized with topical finasteride and minoxidil but saw minimal regrowth. They seek advice on styling and consider oral minoxidil and microneedling for denser hair.

      community scarring alopecia awareness in this community

      in Chat  33 upvotes 2 years ago
      Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

    Related Research

    4 / 4 results